Mylan Pharmaceuticals Inc. has launched 50 mg and 200 mg tablets for its geneirc antipsychotic drug clozapine.


drug store, pharmacy, chain drug store, drugstore, community pharmacy, drug chain, retail pharmacy




























































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Mylan adds new clozapine tablet dosages

April 20th, 2010

PITTSBURGH – Mylan Pharmaceuticals Inc. has launched 50 mg and 200 mg tablets for its geneirc antipsychotic drug clozapine.

The pharmaceutical company, a subsidiary of Mylan Inc., said Monday that those clozapine dosages had U.S. sales of about $13.5 million last year, according to IMS Health data.

Mylan added that the new doses complement its already approved and marketed strengths, which are therapeutically equivalent to Novartis' Clozaril 25 mg and 100 mg.

Clozapine is used for the treatment of schizophrenia and other psychotic disorders, and it's typically reserved for patients who have failed to respond to other medications.

Advertisement